With a rapidly ageing population in Singapore, around 82,000 people are affected by one form of dementia and the number is expected to go beyond 100,000 by 2030. Established in 2010, Memory Ageing and Cognition Centre (MACC) aims to discover scientific insights on the attributing factors of dementia – how it impacts the disease progression and also cognitive impairment in elderly. With a better understanding of the disease, devising interventions that can prolong the patients’ functional independence within the society and delay their institutionalization could lower healthcare burden for patients and their caregivers.
Our MACC team consists of experienced clinicians, professionally trained psychometric raters and research coordinators, who have the expertise and passion to design and conduct novel clinical studies and drug trials in the cognitively impaired or demented in Singapore’s multi-ethnic population.
MACC has up-to-date research facilities – the MACC Assessment unit is equipped with resources and devices for the conduct of clinical and neuropsychological assessments and retinal imaging. Also, MACC has a full BSL-2 laboratory for research located in NUS Medicine MD6 building. Furthermore, we have an active collaboration with Clinical Imaging Research Centre (CIRC) at NUS for high resolution Brain MR Imaging and PET Imaging.
For more information, please visit our webpage:
Connie Teo Kee Ling